Chronic Phase Marker - Global and China Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Medical Care > Chronic Phase Marker - Global and China Top Players Market Share and Ranking 2025

Chronic Phase Marker - Global and China Top Players Market Share and Ranking 2025

Publication Date: 2025-06-11
Report Id: 2237618
Industry: Medical Care
Report Page: 108
Chart: 106

PDF Download

Publication Date: 2025-06-11
Report Id: 2237618
Industry: Medical Care
Report Page: 108
Chart: 106

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Chronic Phase Marker Definition
1.2 Global Chronic Phase Marker Market Size and Forecast
1.3 China Chronic Phase Marker Market Size and Forecast
1.4 Share of China Chronic Phase Marker Market with Respect to the Global Market
1.5 Chronic Phase Marker Market Size: China VS Global Growth Rate, 2020-2031
1.6 Chronic Phase Marker Market Dynamics
1.6.1 Chronic Phase Marker Market Drivers
1.6.2 Chronic Phase Marker Market Restraints
1.6.3 Chronic Phase Marker Industry Trends
1.6.4 Chronic Phase Marker Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Chronic Phase Marker, Global Market Share by Company, 2020-2025
2.2 Global Chronic Phase Marker Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Chronic Phase Marker Concentration Ratio
2.4 Global Chronic Phase Marker Mergers & Acquisitions, Expansion Plans
2.5 Global Chronic Phase Marker Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Chronic Phase Marker, China Market Share by Company, 2020-2025
3.2 China Chronic Phase Marker Chronic Phase Marker Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Chronic Phase Marker Industry Chain
4.2 Chronic Phase Marker Upstream Analysis
4.2.1 Chronic Phase Marker Core Raw Materials
4.2.2 Main Manufacturers of Chronic Phase Marker Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Chronic Phase Marker Production Mode
4.6 Chronic Phase Marker Procurement Model
4.7 Chronic Phase Marker Industry Sales Model and Sales Channels
4.7.1 Chronic Phase Marker Sales Model
4.7.2 Chronic Phase Marker Typical Distributors

5 Sights by Type
5.1 Chronic Phase Marker Classification
5.1.1 Tumor Markers
5.1.2 Cardiac Markers
5.1.3 Thyroid Markers
5.1.4 Others
5.2 by Type, Global Chronic Phase Marker Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Chronic Phase Marker Consumption Value, 2020-2031

6 Sights by Application
6.1 Chronic Phase Marker Segment by Application
6.1.1 Hospitals
6.1.2 Clinics
6.1.3 Diagnostic Laboratories
6.2 by Application, Global Chronic Phase Marker Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Chronic Phase Marker Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global Chronic Phase Marker Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Chronic Phase Marker Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Chronic Phase Marker Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Chronic Phase Marker Market Size Market Share
7.4 Europe
7.4.1 Europe Chronic Phase Marker Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Chronic Phase Marker Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Chronic Phase Marker Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Chronic Phase Marker Market Size Market Share
7.6 South America
7.6.1 South AmericaChronic Phase Marker Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Chronic Phase Marker Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Chronic Phase Marker Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Chronic Phase Marker Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Chronic Phase Marker Market Size, 2020-2031
8.3.2 by Type, United States Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Chronic Phase Marker Market Size, 2020-2031
8.4.2 by Type, Europe Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Chronic Phase Marker Market Size, 2020-2031
8.5.2 by Type, China Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Chronic Phase Marker Market Size, 2020-2031
8.6.2 by Type, Japan Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Chronic Phase Marker Market Size, 2020-2031
8.7.2 by Type, South Korea Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Chronic Phase Marker Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Chronic Phase Marker Market Size, 2020-2031
8.9.2 by Type, India Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Chronic Phase Marker Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Chronic Phase Marker Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 Nordic BioSite
9.1.1 Nordic BioSite Company Information, Head Office, Market Area, and Industry Position
9.1.2 Nordic BioSite Company Profile and Main Business
9.1.3 Nordic BioSite Chronic Phase Marker Models, Specifications, and Application
9.1.4 Nordic BioSite Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.1.5 Nordic BioSite Recent Developments
9.2 DiaSorin
9.2.1 DiaSorin Company Information, Head Office, Market Area, and Industry Position
9.2.2 DiaSorin Company Profile and Main Business
9.2.3 DiaSorin Chronic Phase Marker Models, Specifications, and Application
9.2.4 DiaSorin Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.2.5 DiaSorin Recent Developments
9.3 Roche
9.3.1 Roche Company Information, Head Office, Market Area, and Industry Position
9.3.2 Roche Company Profile and Main Business
9.3.3 Roche Chronic Phase Marker Models, Specifications, and Application
9.3.4 Roche Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.3.5 Roche Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
9.4.2 Bristol-Myers Squibb Company Profile and Main Business
9.4.3 Bristol-Myers Squibb Chronic Phase Marker Models, Specifications, and Application
9.4.4 Bristol-Myers Squibb Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Hologic
9.5.1 Hologic Company Information, Head Office, Market Area, and Industry Position
9.5.2 Hologic Company Profile and Main Business
9.5.3 Hologic Chronic Phase Marker Models, Specifications, and Application
9.5.4 Hologic Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.5.5 Hologic Recent Developments
9.6 QIAGEN
9.6.1 QIAGEN Company Information, Head Office, Market Area, and Industry Position
9.6.2 QIAGEN Company Profile and Main Business
9.6.3 QIAGEN Chronic Phase Marker Models, Specifications, and Application
9.6.4 QIAGEN Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.6.5 QIAGEN Recent Developments
9.7 Philips
9.7.1 Philips Company Information, Head Office, Market Area, and Industry Position
9.7.2 Philips Company Profile and Main Business
9.7.3 Philips Chronic Phase Marker Models, Specifications, and Application
9.7.4 Philips Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.7.5 Philips Recent Developments
9.8 Johnson & Johnson
9.8.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
9.8.2 Johnson & Johnson Company Profile and Main Business
9.8.3 Johnson & Johnson Chronic Phase Marker Models, Specifications, and Application
9.8.4 Johnson & Johnson Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.8.5 Johnson & Johnson Recent Developments
9.9 Lifesign
9.9.1 Lifesign Company Information, Head Office, Market Area, and Industry Position
9.9.2 Lifesign Company Profile and Main Business
9.9.3 Lifesign Chronic Phase Marker Models, Specifications, and Application
9.9.4 Lifesign Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.9.5 Lifesign Recent Developments
9.10 Natus
9.10.1 Natus Company Information, Head Office, Market Area, and Industry Position
9.10.2 Natus Company Profile and Main Business
9.10.3 Natus Chronic Phase Marker Models, Specifications, and Application
9.10.4 Natus Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.10.5 Natus Recent Developments
9.11 BrainScope
9.11.1 BrainScope Company Information, Head Office, Market Area, and Industry Position
9.11.2 BrainScope Company Profile and Main Business
9.11.3 BrainScope Chronic Phase Marker Models, Specifications, and Application
9.11.4 BrainScope Chronic Phase Marker Revenue and Gross Margin, 2020-2025
9.11.5 BrainScope Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Chronic Phase Marker should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood. Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient’s body.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Chronic Phase Marker market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Chronic Phase Marker market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Hospitals grew percent to account for percent of the total market sales, and Clinics grew percent.

This report studies and analyses global Chronic Phase Marker status and future trends, to help determine the Chronic Phase Marker market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Chronic Phase Marker, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Chronic Phase Marker market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global Chronic Phase Marker by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China Chronic Phase Marker by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global Chronic Phase Marker key consuming regions, consumption value and demand structure
(5) Chronic Phase Marker industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Nordic BioSite
DiaSorin
Roche
Bristol-Myers Squibb
Hologic
QIAGEN
Philips
Johnson & Johnson
Lifesign
Natus
BrainScope

Market segment by Type, covers
Tumor Markers
Cardiac Markers
Thyroid Markers
Others

Market segment by Application, can be divided into
Hospitals
Clinics
Diagnostic Laboratories

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Chronic Phase Marker product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Chronic Phase Marker market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China Chronic Phase Marker market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: Chronic Phase Marker industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions